{"id":"W4225303623","doi":"10.1007/s40257-022-00685-0","title":"Dupilumab Provides Acceptable Safety and Sustained Efficacy for up to 4 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis","year":2022,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"ca_institutions":"Innovaderm (Canada)","funders":"Glenmark Pharmaceuticals; LEO Pharma; Galderma; Incyte; Dermira; Regeneron Pharmaceuticals; Sanofi; Pfizer; Eli Lilly and Company","keywords":"Dupilumab; Medicine; Atopic dermatitis; Dermatology; Pharmacotherapy; Off-label use; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005164418,0.0001679386,0.001618963,0.0002758865,0.000111262,0.00002051377,0.0004327479,0.00005378318,0.00005228236],"category_scores_gemma":[0.0008297126,0.0001427242,0.00005906731,0.0004259548,0.0002357539,0.0001927589,0.0002831159,0.000403621,0.000001226518],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003690159,"about_ca_system_score_gemma":0.0005189425,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000807227,"about_ca_topic_score_gemma":0.0001669614,"domain_scores_codex":[0.9968239,0.0007562524,0.001517474,0.0003255889,0.0002502869,0.0003264756],"domain_scores_gemma":[0.9972966,0.001015947,0.0006577898,0.0003035982,0.0002926677,0.0004333531],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.07169889,0.007953848,0.8511285,0.000137354,0.000419022,0.002126475,0.005999143,0.000453332,0.000005641165,0.0001243171,0.003408798,0.05654473],"study_design_scores_gemma":[0.05902665,0.0250232,0.8792073,0.000138126,0.000265101,0.004135609,0.02897153,0.0006598834,0.00001508516,0.00009522235,0.002199269,0.00026306],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.994107,0.00007905837,0.0002211031,0.003780116,0.0001257917,0.001607563,0.00001979731,0.000009601719,0.00004995068],"genre_scores_gemma":[0.9943585,0.00002480537,0.002173254,0.003266504,0.00002596882,0.00007744227,0.000008267946,0.00002515265,0.00004010963],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05628167,"threshold_uncertainty_score":0.5820125,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.036607971002882,"score_gpt":0.388442262458741,"score_spread":0.351834291455859,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}